Ribonucleic Acid News and Research

RSS

Early impact of SARS-CoV-2 on human lungs

In a new study, researchers assessed the impact of coronavirus disease 2019 (COVID-19) on human lung cells.

16 May 2022

SARS-CoV-2 Omicron BA.2 differs antigenically from previous variants

Researchers observed that the SARS-CoV-2 Omicron BA.2 variant is immunologically different from other variants, including Omicron BA.1.

16 May 2022

Exploring age-associated differences in T lymphocyte immune responses after BNT162b2 vaccination

Researchers compared the immunogenicity of or and reactogenicity to the BNT162b2 vaccine in Japanese adults and elders.

16 May 2022

Study shows dengue virus can lower sperm production in men

A new study supports the notion that the dengue virus can be sexually transmissible for a short period after acute dengue illness and that it can also cause alterations in sperm production.

16 May 2022

The potential role of the gut microbiome in modifying patient responses to statin therapy

Researchers discovered strong links between human gut microbiome makeup and statin on- and off-target effects, probably beneficial in medication tailoring.

13 May 2022

Direct infection and replication of influenza virus in cardiomyocytes is a primary determinant of cardiac pathology associated with severe influenza

Researchers generated a recombinant influenza virus expressing micro ribonucleic acid (miRNAs) expressed in cardiomyocytes to infect mice, which served as a model to study the etiology of influenza-associated cardiac pathology.

13 May 2022

The safety, immunogenicity, and efficacy of the mRNA-1273 vaccine in children aged 6-11

In a recent study published in The New England Journal of Medicine, researchers evaluated the safety, immunogenicity, and efficacy of the messenger ribonucleic acid (mRNA)-1273 vaccine in children.

13 May 2022

Phase 1 trial of COVID-19 PTXCOVID19-B vaccine

A new study demonstrated that the SARS-CoV-2 PTXCOVID19-B vaccine was a promising SARS-CoV-2 vaccine option.

12 May 2022

COVID-19 booster vaccination strategy found to be highly cost-effective in Australia

Researchers evaluated the cost-effectiveness of Australia’s COVID-19 booster vaccination strategy.

12 May 2022

Imprinted antibody responses towards SARS-CoV-2 Omicron subvariants

A new study analyzed the imprinted antibody responses towards the SARS-CoV-2 Omicron subvariants.

12 May 2022

Messenger RNA COVID-19 vaccines induce high levels of short-lived antibodies compared to natural infection

Researchers extensively investigated the dynamics of antibodies induced by natural SARS-CoV-2 infection and vaccination in Qatar's diverse population

12 May 2022

Research looks at potential of pantethine against SARS-CoV-2

In a recent study posted to the Research Square preprint server, researchers assessed the antiviral activity of pantethine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

12 May 2022

Study estimates effectiveness of 2-dose and 3-dose mRNA vaccination against Omicron

In a recent study posted to the medRxiv* preprint server, researchers estimated the efficacy of two-dose and three-dose regimens of two messenger ribonucleic acid (mRNA) vaccines: Moderna’s mRNA-1273 and Pfizer-BioNTech’s BNT162b2 against coronavirus disease 2019 (COVID-19) caused due to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant.

12 May 2022

SARS-CoV-2 Omicron escapes immune response due to high ACE2 affinity and low antibody specificity

In a recent study published in the journal Vaccines, researchers revealed how severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) Omicron evades neutralizing antibodies (nAbs).

12 May 2022

Antifungal agent Bifonazole as an antiviral against SARS-CoV-2

In a recent study published in the journal Molecular Therapy, researchers identified Bifonazole, an imidazole-based antifungal agent, to have potent activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using high-throughput screening of small molecules.

12 May 2022

Ribonucleic Acid News and Research

Early impact of SARS-CoV-2 on human lungs

SARS-CoV-2 Omicron BA.2 differs antigenically from previous variants

Exploring age-associated differences in T lymphocyte immune responses after BNT162b2 vaccination

Study shows dengue virus can lower sperm production in men

The potential role of the gut microbiome in modifying patient responses to statin therapy

Direct infection and replication of influenza virus in cardiomyocytes is a primary determinant of cardiac pathology associated with severe influenza

The safety, immunogenicity, and efficacy of the mRNA-1273 vaccine in children aged 6-11

Phase 1 trial of COVID-19 PTXCOVID19-B vaccine

COVID-19 booster vaccination strategy found to be highly cost-effective in Australia

Imprinted antibody responses towards SARS-CoV-2 Omicron subvariants

Messenger RNA COVID-19 vaccines induce high levels of short-lived antibodies compared to natural infection

Research looks at potential of pantethine against SARS-CoV-2

Study estimates effectiveness of 2-dose and 3-dose mRNA vaccination against Omicron

SARS-CoV-2 Omicron escapes immune response due to high ACE2 affinity and low antibody specificity

Antifungal agent Bifonazole as an antiviral against SARS-CoV-2

The promise of RNA medicine is targeted and personalized

Review portrays clinical journey of messenger RNA vaccines and mRNA-based therapies

COVID-19-induced non-cell-autonomous anosmia

Decoy ACE2 nanoparticles block the entry of SARS-CoV-2 into cells

Exploring simultaneous and sequential COVID-19 vaccine candidate

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News